Limited Competition: Small Grant Program for NHLBI Career Development Recipients (Clinical Trial Optional)
ID: 359675Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359675
Timeline
    Description

    The National Institutes of Health (NIH) is announcing a Limited Competition Small Grant Program aimed at NHLBI Career Development recipients, with the option for clinical trials. This funding opportunity is designed to support current or recently completed NHLBI career development awardees in expanding their research objectives or initiating new studies stemming from their previous work, particularly to assist those transitioning to research independence. The program is crucial for generating preliminary data and publications that facilitate the transition from K-awards to R-awards. While applications are not currently being solicited, interested investigators are encouraged to prepare for future submissions, with the estimated synopsis posting date set for March 1, 2026, and a projected award date of October 1, 2026. For further inquiries, potential applicants can contact the NHLBI at nhlbidld_grants@nhlbi.nih.gov.

    Point(s) of Contact
    National Heart, Lung, and Blood Institute (NHLBI)
    N/A
    nhlbidld_grants@nhlbi.nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program (R03) aimed at supporting current or recently completed NHLBI K01, K08, K23, and K25 awardees in enhancing their research capabilities as they transition to independent investigator roles. This funding opportunity allows eligible applicants to receive up to $75,000 per year for short-term research projects that can be completed within two years, focusing on activities such as pilot studies, proof of concept evaluations, and methodological development that generate preliminary data for future R01 applications. The program emphasizes the importance of fostering a diverse scientific workforce and is open for applications from January 13, 2023, with a closing date of January 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), has announced a Limited Competition Small Grant Program aimed at supporting current and recently completed K01, K08, K23, and K25 award recipients. This funding opportunity, designated as RFA-HL-25-011, allows eligible applicants to secure up to $75,000 per year for projects lasting up to two years, with the goal of generating preliminary data for subsequent R01-equivalent applications. The program is particularly focused on advancing early-stage investigators towards independent research careers, emphasizing the inclusion of underrepresented groups in biomedical research. Interested applicants must adhere to strict submission guidelines via Grants.gov, with a close date for applications set for January 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NHLBI Career Transition Award (K22), a federal grant aimed at supporting postdoctoral fellows and doctoral-level researchers transitioning from intramural NIH research to independent extramural research. This program features a two-phase support structure: an up to two-year mentored intramural phase followed by a three-year extramural phase, contingent upon a successful review of the awardee's research progress. The grant is designed to cultivate future researchers capable of addressing critical health-related questions and enhancing the scientific community, with an emphasis on diversity and inclusion of underrepresented groups. Interested applicants must have a relevant doctoral degree and adhere to stringent application instructions, with proposals due starting September 12, 2024. For further details, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and the opportunity is open until July 12, 2027.
    Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program aimed at recipients of specific NIDDK career development awards (K01, K08, K23, K25) to support their research during the latter years of their awards. This program is designed to enhance the transition to independent research by allowing these recipients to conduct pilot studies, secondary analyses, and other small projects, which are crucial for generating publications and data necessary for future R01 applications. The grant provides direct costs of up to $75,000 per year for a maximum of two years, with applications required to include a Plan for Enhancing Diverse Perspectives (PEDP) as part of the review process. Interested applicants should note that the submission period opens on January 16, 2025, with subsequent deadlines through January 2028, and can direct inquiries to grantsinfo@nih.gov for further information.
    NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NHLBI Career Transition Award (K22) aimed at supporting postdoctoral fellows and research trainees in transitioning their research programs to extramural institutions as junior investigators. This grant provides a structured five-year program, which includes a mentored intramural phase of up to two years followed by an independent extramural phase lasting three years, contingent upon successful progress during the mentored phase. The program is designed to cultivate a diverse pool of skilled investigators to meet national biomedical research needs, with eligibility requirements including a doctoral degree and a maximum of five years of postdoctoral research experience within the NHLBI. Interested applicants should note that the application deadline is July 12, 2027, and they can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found in the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-209.html.
    Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a limited competition grant opportunity titled "Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03)," aimed at enhancing the research capabilities of early-career scientists supported by NIAMS. This program is specifically designed for recipients of K awards who are in the second to fourth year of their funding, allowing them to apply for R03 support to conduct small, self-contained research projects, pilot studies, or develop new research methodologies, with the stipulation that clinical trials are not permitted. Interested applicants should note that while applications are not currently being solicited, they are encouraged to prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of August 20, 2025, and a closing date of October 20, 2025. For further inquiries, potential applicants can contact Su-Yau Mao, Ph.D., at su-yau.mao@nih.gov or by phone at 301-451-1945.
    NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the NHLBI Early Phase Clinical Trials (R33), aimed at supporting investigator-initiated Phase I clinical trials for therapeutic and diagnostic interventions targeting heart, lung, blood, and sleep (HLBS) disorders. Applicants are required to be prepared to initiate their clinical trials within the first quarter of the project period and must demonstrate readiness in obtaining necessary regulatory approvals, including FDA and IRB, prior to the award. This funding is crucial for addressing unmet medical needs through innovative research, with a maximum budget of $1.515 million per year and a project duration of up to three years, contingent upon achieving specific milestones. Interested applicants should note the application deadline of June 4, 2024, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov for further details.
    NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity aimed at supporting Phase I clinical trials for therapeutic and diagnostic interventions related to heart, lung, blood, and sleep (HLBS) disorders. This initiative seeks to accelerate the development of clinical interventions by funding investigator-initiated studies that demonstrate potential advancements in HLBS health, with a focus on ensuring that applicants are prepared to initiate trials promptly after receiving funding. The funding is capped at $1.5 million per year for a project period of up to three years, contingent on satisfactory progress and milestone completion, with applications opening on January 3, 2025, and the first due date set for February 3, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-25-025.html.
    NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Clinical Trial Pilot Studies (R34 Clinical Trial Optional) through the National Heart, Lung, and Blood Institute (NHLBI). This initiative aims to support research that provides essential information for the design of future Phase II-IV clinical trials focused on heart, lung, blood, and sleep disorders, requiring applicants to demonstrate the scientific necessity and sufficiency of their proposed studies. The NHLBI emphasizes inclusivity by mandating a Plan for Enhancing Diverse Perspectives (PEDP) to enhance the project's scientific merit, with a budget of up to $450,000 in direct costs available over a maximum project period of three years. Interested applicants should note that the application period opens on January 16, 2025, and the final submission deadline is January 7, 2027; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.
    NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders," aimed at supporting investigator-initiated Phase I clinical trials for heart, lung, blood, and sleep (HLBS) disorders in both adults and children. This grant (R61/R33) facilitates funding for essential preclinical activities and the execution of clinical trials, structured in two phases: the R61 phase focuses on preparatory tasks, while the R33 phase involves the actual trial conduct, guided by specific milestones. This initiative is crucial for advancing research that addresses significant health challenges associated with HLBS disorders. Interested applicants can submit proposals starting January 3, 2025, with a maximum project period of five years, and should direct inquiries to grantsinfo@nih.gov. For more details, visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-026.html.